Table 4.
Multivariate analysis of progression free survival (A) and overall survival (B) for KRAS versus pan-mutation negative patients.
A. Progression-free survival | ||
Variable | HR | p-value |
KRAS | 1.56 (95% CI: 1.09-2.23) | 0.015 |
Sex (W vs M) | 1.30 (95% CI: 0.91-1.85) | 0.152 |
Smoking (Y vs N) | 1.64 (95% CI: 0.92-2.93) | 0.091 |
B. Overall survival | ||
Variable | HR | p-value |
KRAS | 1.73 (95% CI: 1.12-2.67) | 0.014 |
Sex (W vs M) | 1.67 (95% CI: 1.07-2.61) | 0.025 |
Smoking (Y vs N) | 1.34 (95% CI: 0.68-2.63) | 0.399 |